DONG MA: Open Payments
NPI 1598212946 · TWIN FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 13 payments from 9 companies in 2025. Trend: 2023 $394 · 2024 $772 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| ABBVIE INC. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Incyte Corporation | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $21 |
| Eisai Inc. | 1 | $21 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $14 |
Products named: KISQALI, MONJUVI, LUTATHERA, EPKINLY, CARVYKTI, CREON, Lenvima, NERLYNX.
Industry payments across ID — which companies pay providers there.
